"Designed by Scientists for Scientists"
Our mission is to empower organizations of all sizes with cutting-edge informatics solutions that accelerate scientific discovery and drive research innovation
About Us
Scilligence is a leading provider of AI-enabled cheminformatics and bioinformatics solutions, seamlessly integrating advanced informatics, automation, and robotics technologies. We serve pharmaceutical, biotechnology, and chemical organizations with state-of-the-art software platforms designed to accelerate discovery, streamline research workflows, and maximize R&D productivity. Through partnerships with universities, research institutes, and government agencies, we equip scientists with innovative tools that support groundbreaking research and help train the next generation of scientific leaders. Scilligence is recognized as an industry leader in delivering a unified informatics platform that supports all major therapeutic modalities, including small molecules, peptides, oligonucleotides, antibodies, and antibody-drug conjugates (ADCs).
Since 2011, our software has been purpose-built by scientists for scientists, ensuring that every solution is aligned with the realities of modern research environments. Our multidisciplinary team of chemists, biologists, and data scientists brings deep scientific expertise to every stage of product development. Having experienced the challenges of managing complex scientific data firsthand, we design intuitive, scalable solutions that address the evolving needs of researchers and enable more efficient, data-driven innovation.
What our Icon stands for.
Our logo embodies the core values of Scilligence: innovation, collaboration, and perseverance. It reflects the essential elements that define our brand. What distinguishes Scilligence is our unique, all-in-one informatics platform, integrating both cheminformatics and bioinformatics to support a wide range of drug modalities, represented by the benzene ring for small molecules and the alpha helix for biologics. Beyond its scientific strengths, Scilligence’s solutions are designed to foster internal and external collaboration and drive data-driven innovation. The sliced design of the logo symbolizes these dynamic, action-oriented qualities.
Our Core Values
Innovation
Innovation drives our mission to reshape drug discovery and development. Our integrated informatics platform combines cheminformatics and bioinformatics, equipping researchers with advanced tools to explore a range of drug modalities and develop transformative therapies. By harnessing adaptable workflows and data-driven insights, Scilligence enables scientific teams to uncover new possibilities in life sciences, pushing the boundaries of what’s achievable in the pursuit of patient-centered solutions. We’re committed to providing technology that evolves alongside the field, empowering scientists to innovate with confidence and clarity.
Collaboration
Collaboration is essential to Scilligence’s approach, as we recognize the power of collective expertise in advancing scientific progress. Our platform facilitates seamless communication and data sharing, bringing together diverse teams across departments, organizations, and disciplines. By supporting both internal and external collaboration, Scilligence’s solutions help unify scientific goals, break down silos, and streamline processes, ensuring that each milestone in research and development is a shared achievement. This commitment to collaboration reflects our belief that when minds connect, scientific breakthroughs follow.
Perseverance
Perseverance is at the core of Scilligence’s commitment to advancing life sciences, even in the face of challenges. Our solutions are designed to support scientists throughout every phase of the research process, from early discovery to late development. Scilligence provides resilient tools that adapt to both evolving demands and future scientific challenges, enabling teams to overcome setbacks and stay focused on their mission. This dedication to perseverance reflects our role as a reliable partner to researchers, one that is steadfastly committed to moving forward alongside our partners to bring new therapies closer to those who need them.